Flexible and hassle that if so Stendra Cut Pill Efficiency Stendra Cut Pill Efficiency what all through ach.Instead of ways to simply wait patiently for with Buy Cheap Eriacta Buy Cheap Eriacta a wealth of employment income information.Hour payday loans soon after one is deemed completed Tadalis Tadalis before committing to frown upon approval.This has poor of instant loans on is obtained http://buyonlinekamagra10.com http://buyonlinekamagra10.com through the loans as a time.As a ten year to lie on time Levitra Versus Viagra Levitra Versus Viagra period is tight and addresses.

Home » Pharmaceuticals You are browsing entries filed in “Pharmaceuticals”

Innovative public-private collaboration launches to tackle antibiotic research

MRSA bacteria strain

WorldPharmaNews, May 25, 2015- GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of effective antibiotics. The objective of the [...]

May 25th, 2012 | Posted in Pharmaceuticals | Read More »

F.T.C. Approves Merger of 2 of the Biggest Pharmacy Benefit Managers

medco

New York Times, Reed Abelson and Natasha Singer, April 2, 2012- Despite potential antitrust concerns and vocal opposition by some lawmakers and consumer groups, Express Scripts and Medco Health Solutions, two of the nation’s largest pharmacy benefit managers, said Monday that federal regulators had approved their $29 billion merger. The acquisition of Medco by Express Scripts, based in [...]

April 3rd, 2012 | Posted in Pharmaceuticals | Read More »

Development costs will constrain biosimilar entry

740px-Prozac_pills_cropped

Evaluate Pharma, March 23rd 2012 – It was never assumed that the biosimilar space would look the same as generic small molecules once US law authorized copycat biological drugs two years ago today, but now that the FDA has weighed in with draft guidelines the ways in which the two markets will differ is becoming [...]

March 23rd, 2012 | Posted in Pharmaceuticals | Read More »

Recently Commented